Differences between the European and Eurasian Good Pharmacovigilance Practices

Good pharmacovigilance practices (GVP) of the Eurasian Economic Union (EAEU) were prepared based on the GVP of the European Medicines Agency that have been in force in the European Union (EU) since 2012. The EAEU GVP have been in force in the Russian Federation and the other EAEU member states since...

Full description

Bibliographic Details
Main Authors: A. V. Matveev, A. E. Krasheninnikov, E. A. Matveeva, B. K. Romanov
Format: Article
Language:Russian
Published: Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products» of the Ministry of Health of the Russian Federation  2021-07-01
Series:Безопасность и риск фармакотерапии
Subjects:
gvp
Online Access:https://www.risksafety.ru/jour/article/view/220